TELA
Tela Bio Inc
NASDAQ: TELA · HEALTHCARE · MEDICAL DEVICES
$0.87
+1.72% today
Updated 2026-04-30
Market cap
$34.90M
P/E ratio
—
P/S ratio
0.44x
EPS (TTM)
$-0.83
Dividend yield
—
52W range
$1 – $2
Volume
0.2M
Tela Bio Inc (TELA) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $15.53M | $27.23M | $67.92M | $86.46M | $62.54M | $67.86M | $78.05M | $87.33M |
| Cash & equivalents | $11.35M | $17.28M | $45.30M | $74.39M | $43.93M | $42.02M | $46.73M | $52.67M |
| Current assets | $14.35M | $23.25M | $64.33M | $83.22M | $59.05M | $62.45M | $71.73M | $78.07M |
| Total liabilities | $123.70M | $165.09M | $36.96M | $37.43M | $42.45M | $53.55M | $59.17M | $58.87M |
| Current liabilities | $6.15M | $9.56M | $6.71M | $6.61M | $10.57M | $12.40M | $16.97M | $15.60M |
| Long-term debt | $3.61M | $29.73M | $30.24M | $30.83M | $31.49M | $39.92M | $40.52M | $41.12M |
| Shareholder equity | $-108.17M | $-137.86M | $30.96M | $49.03M | $20.10M | $14.30M | $18.88M | $28.46M |
| Retained earnings | $-108.17M | $-137.86M | $-167.86M | $-196.65M | $-229.93M | $-274.23M | $-320.89M | $-358.73M |
| Accounts receivable | $757000.00 | $1.30M | $2.84M | $2.68M | $4.23M | $6.62M | $9.74M | $10.10M |
| Inventory | $1.81M | $4.35M | $4.60M | $3.91M | $7.66M | $11.79M | $13.16M | $12.78M |
| Goodwill | — | — | — | — | — | — | — | — |